Compare
Hyperliquid Strategies Inc vs Chime Financial, Inc. vs Yiren Digital Ltd. vs Core Scientific, Inc./tx
| Latest fiscal year | Hyperliquid Strategies Inc PURRRevenue covers only part of its income (partial revenue) | Chime Financial, Inc. CHYM | Yiren Digital Ltd. YRD | Core Scientific, Inc./tx CORZ |
|---|---|---|---|---|
| Year ended | 2026-06-30 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | n/a | $2.19B | $817.84M | $319.02M |
| Revenue growth (YoY) | n/a | +30.7% | n/a | -37.5% |
| Gross margin | n/a | 88.0% | n/a | 11.9% |
| Operating margin | n/a | -47.6% | -103.9% | -77.0% |
| Net margin | n/a | -46.2% | 1.0% | -90.5% |
| Net income | $305.54M | -$1.01B | $7.80M | -$288.62M |
| EPS (Diluted) | $3.21 | -$4.27 | $0.0446 | -$0.88 |
| Operating cash flow | -$19.15M | $52.78M | $100.62M | $278.25M |
| Free cash flow | n/a | $32.89M | $96.94M | -$450.75M |
| Cash & equivalents | $137.92M | $466.25M | $478.78M | $311.38M |
| Total assets | $2.06B | $1.96B | $1.92B | $2.35B |
| Total liabilities | $187.14M | $562.90M | $598.15M | $3.31B |
| Shareholders' equity | $1.87B | $1.40B | $1.33B | -$962.74M |
| Return on year-end equity | 16.3% | -72.1% | 0.6% | n/a |
| Shares outstanding | 200.55M | n/a | 174.68M | 314.23M |
Revenue, most recent five fiscal years
| Fiscal year | Hyperliquid Strategies Inc | Chime Financial, Inc. | Yiren Digital Ltd. | Core Scientific, Inc./tx |
|---|---|---|---|---|
| Latest | n/a | $2.19B Ended 2025-12-31 | $817.84M Ended 2025-12-31 | $319.02M Ended 2025-12-31 |
| 1 year earlier | n/a | $1.67B Ended 2024-12-31 | n/a | $510.67M Ended 2024-12-31 |
| 2 years earlier | n/a | $1.28B Ended 2023-12-31 | n/a | $502.40M Ended 2023-12-31 |
| 3 years earlier | n/a | n/a | n/a | $640.31M Ended 2022-12-31 |
| 4 years earlier | n/a | n/a | n/a | $544.48M Ended 2021-12-31 |